{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T09:32:29Z","timestamp":1768987949113,"version":"3.49.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.bcp.2011.06.035","type":"journal-article","created":{"date-parts":[[2011,7,5]],"date-time":"2011-07-05T20:15:09Z","timestamp":1309896909000},"page":"746-754","source":"Crossref","is-referenced-by-count":17,"title":["Pharmacological profile of FK881(ASP6537), a novel potent and selective cyclooxygenase-1 inhibitor"],"prefix":"10.1016","volume":"82","author":[{"given":"Junko","family":"Imanishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Yoshimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanae","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Masunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Yamagami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Kuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emi","family":"Hamachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumie","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Ohkubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seitaro","family":"Mutoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2011.06.035_bib0005","first-page":"50","article-title":"Understanding NSAIDs: from aspirin to COX-2 clinical","volume":"3","author":"Gary","year":"2001","journal-title":"Cornerstone Sports Med"},{"key":"10.1016\/j.bcp.2011.06.035_bib0010","doi-asserted-by":"crossref","first-page":"11693","DOI":"10.1073\/pnas.90.24.11693","article-title":"Selectivity of non-steroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase","volume":"90","author":"Mitchell","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2011.06.035_bib0015","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1073\/pnas.91.8.3228","article-title":"Selective inhibition of inducible cyclooxygenase 2 in vivo is anti-inflammatory and nonulcerogenic","volume":"91","author":"Masferrer","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2011.06.035_bib0020","doi-asserted-by":"crossref","first-page":"12013","DOI":"10.1073\/pnas.91.25.12013","article-title":"Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain","volume":"91","author":"Seibert","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2011.06.035_bib0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI200113418","article-title":"Cyclooxygenase selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs","volume":"108","author":"Patrono","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2011.06.035_bib0030","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1053\/gast.1997.v112.pm9041264","article-title":"Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years","volume":"112","author":"Wallace","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2011.06.035_bib0035","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs. nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA."},{"key":"10.1016\/j.bcp.2011.06.035_bib0040","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group","volume":"343","author":"Bombardier","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bcp.2011.06.035_bib0045","first-page":"1568","article-title":"Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding","volume":"62","author":"Masso","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bcp.2011.06.035_bib0050","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0092-8674(95)90126-4","article-title":"Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration","volume":"83","author":"Langenbach","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2011.06.035_bib0055","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/gast.2002.33647","article-title":"COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice","volume":"122","author":"Sigthorsson","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2011.06.035_bib0060","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/gast.2000.16510","article-title":"NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2","volume":"119","author":"Wallace","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2011.06.035_bib0065","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/sj.bjp.0703955","article-title":"Effects of specific inhibition of cyclooxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge","volume":"132","author":"Gretzer","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.035_bib0070","first-page":"21","article-title":"Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal antiinflammatory drugs","volume":"95","author":"Tanaka","year":"2001","journal-title":"J Physiol"},{"issue":"Suppl 2","key":"10.1016\/j.bcp.2011.06.035_bib0075","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1365-2036.16.s2.22.x","article-title":"Up-regulation of COX-2 by inhibition of COX-1 in the rat: a key to NSAID-induced gastric injury","volume":"16","author":"Tanaka","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bcp.2011.06.035_bib0080","unstructured":"Celecoxib for arthritis. Med Lett Drugs Ther 1999; 41: 11\u20132."},{"key":"10.1016\/j.bcp.2011.06.035_bib0085","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/PL00000227","article-title":"FK506 is superior to methotrexate in therapeutic effects on advanced stage of rat adjuvant-induced arthritis","volume":"50","author":"Sakuma","year":"2001","journal-title":"Inflamm Res"},{"key":"10.1016\/j.bcp.2011.06.035_bib0090","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/BF02342223","article-title":"Predictability of the clinical potency of NSAIDs from the preclinical pharmacodynamics in rats","volume":"45","author":"Mukherjee","year":"1996","journal-title":"Inflamm Res"},{"key":"10.1016\/j.bcp.2011.06.035_bib0095","first-page":"563","article-title":"Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs","volume":"53","author":"Terlain","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.bcp.2011.06.035_bib0100","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0022-3565(24)38776-2","article-title":"Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2","volume":"296","author":"Riendeau","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2011.06.035_bib0105","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1177\/009127000004001005","article-title":"Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX2 versus COX1 in healthy volunteers. [Clinical Trial. Journal Article. Randomized Controlled Trial]","volume":"40","author":"Hecken","year":"2000","journal-title":"J Clin Pharmacol"},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2011.06.035_bib0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2165\/00003495-200363001-00005","article-title":"Inhibition of PGE2 production by nimesulide compared with diclofenac in the acutely inflamed joint of patients with arthritis","volume":"63","author":"Duffy","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.bcp.2011.06.035_bib0115","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0022-3565(24)34934-1","article-title":"Rofecoxib [Vioxx, MK-0966; 4-(4\u2032-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles","volume":"290","author":"Chan","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2011.06.035_bib0120","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0009-9236(99)70113-X","article-title":"Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model","volume":"65","author":"Ehrich","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bcp.2011.06.035_bib0125","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.pnpbp.2004.01.015","article-title":"Isobolographic analysis of interaction between cyclooxygenase inhibitors and tramadol in acetic acid-induced writhing in mice","volume":"28","author":"Satyanarayana","year":"2004","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bcp.2011.06.035_bib0130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0014-2999(00)00051-0","article-title":"The analgesic effect profile of FR122047, a selective cyclooxygenase-1 inhibitor, in chemical nociceptive models","volume":"391","author":"Ochi","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.035_bib0135","doi-asserted-by":"crossref","first-page":"10272","DOI":"10.1073\/pnas.180319297","article-title":"Nociception in cyclooxygenase isozyme-deficient mice","volume":"97","author":"Ballou","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2011.06.035_bib0140","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/41780","article-title":"Altered pain perception and inflammatory response in mice lacking prostacyclin receptor","volume":"388","author":"Murata","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2011.06.035_bib0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0014-2999(98)00340-9","article-title":"Induction of cyclooxygenase-2 causes an enhancement of writhing response in mice","volume":"352","author":"Matsumoto","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.035_bib0150","first-page":"211","article-title":"Differential antinociceptive effect of cyclooxygenase inhibitors in acetic acid-induced chemonociception in mice","volume":"5","author":"Jain","year":"2001","journal-title":"Analgesia"},{"key":"10.1016\/j.bcp.2011.06.035_bib0155","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0014-5793(96)00604-7","article-title":"Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation","volume":"390","author":"Beiche","year":"1996","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2011.06.035_bib0160","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1163\/156856004773121374","article-title":"Effect of selective inhibition of cyclooxygenase-2 on lipopolysaccharide-induced hyperalgesia","volume":"12","author":"Satyanarayana","year":"2004","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.bcp.2011.06.035_bib0165","doi-asserted-by":"crossref","first-page":"13313","DOI":"10.1073\/pnas.95.22.13313","article-title":"Pharmacological analysis of cyclooxygenase-1 in inflammation","volume":"95","author":"Smith","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2011.06.035_bib0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.2042-7158.1972.tb08940.x","article-title":"Biological properties of carrageenan","volume":"24","author":"Massimo","year":"1972","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.035_bib0175","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0304-3959(87)90117-5","article-title":"Evidence that adjuvant arthritis in the rat is associated with chronic pain","volume":"28","author":"Colpaert","year":"1987","journal-title":"Pain"},{"key":"10.1016\/j.bcp.2011.06.035_bib0180","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0090-6980(97)00128-7","article-title":"Cyclooxygenases and the central nervous system","volume":"54","author":"Kaufmann","year":"1997","journal-title":"Prostaglandins"},{"key":"10.1016\/j.bcp.2011.06.035_bib0185","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1113\/jphysiol.1971.sp009620","article-title":"Effects on body temperature of prostaglandins of the A, E and F series on injection into the third ventricle of unanaesthetized cats and rabbits","volume":"218","author":"Milton","year":"1971","journal-title":"J Physiol"},{"key":"10.1016\/j.bcp.2011.06.035_bib0190","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/26233","article-title":"Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3","volume":"395","author":"Ushikubi","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2011.06.035_bib0195","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0006-8993(99)01225-1","article-title":"The febrile response to lipopolysaccharide is blocked in cyclooxygenase-2(\u2212\/\u2212), but not in cyclooxygenase-1(\u2212\/\u2212) mice","volume":"825","author":"Li","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.bcp.2011.06.035_bib0200","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0006-8993(95)00839-I","article-title":"Induction by lipopolysaccharide of cyclooxygenase-2 mRNA in rat brain; its possible role in the febrile response","volume":"697","author":"Cao","year":"1995","journal-title":"Brain Res"},{"key":"10.1016\/j.bcp.2011.06.035_bib0205","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0006-8993(96)00575-6","article-title":"Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1 beta: a possible site of prostaglandin synthesis responsible for fever","volume":"733","author":"Cao","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.bcp.2011.06.035_bib0210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0169-328X(98)00025-4","article-title":"Cyclooxygenase-2 is induced in brain blood vessels during fever evoked by peripheral or central administration of tumor necrosis factor","volume":"56","author":"Cao","year":"1998","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.bcp.2011.06.035_bib0215","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bbrc.2007.10.033","article-title":"Peripheral TNFalpha, but not peripheral IL-1, requires endogenous IL-1 or TNFalpha induction in the brain for the febrile response","volume":"364","author":"Chida","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2011.06.035_bib0220","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s000110050225","article-title":"Pharmacological profile of JTE-522, a novel prostaglandin H synthase-2 inhibitor, in rats","volume":"46","author":"Matsushita","year":"1997","journal-title":"Inflamm Res"},{"key":"10.1016\/j.bcp.2011.06.035_bib0225","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0306-3623(93)90018-S","article-title":"NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions","volume":"24","author":"Futaki","year":"1993","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.bcp.2011.06.035_bib0230","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0009-9236(99)90087-5","article-title":"Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans","volume":"65","author":"Schwartz","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bcp.2011.06.035_bib0235","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/13693780400011112","article-title":"Toll-like receptors as key mediators in innate antifungal immunity","volume":"42","author":"Roeder","year":"2004","journal-title":"Med Mycol"},{"key":"10.1016\/j.bcp.2011.06.035_bib0240","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cyto.2007.11.003","article-title":"Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome","volume":"41","author":"Malleo","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.bcp.2011.06.035_bib0245","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/S0024-3205(00)00804-3","article-title":"Candida albicans and Saccharomyces cerevisiae cell wall mannans produce fever in rats. Role of nitric oxide and cytokines","volume":"67","author":"Ataoglu","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.bcp.2011.06.035_bib0250","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1248\/bpb.17.1577","article-title":"Anti-inflammatory effects of etodolac: comparison with other non-steroidal anti-inflammatory drugs","volume":"17","author":"Inoue","year":"1994","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.bcp.2011.06.035_bib0255","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1080\/00365520510015827","article-title":"COX-1 and COX-2 conversely promote and suppress ischemia-reperfusion gastric injury in mice","volume":"40","author":"Hiratsuka","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bcp.2011.06.035_bib0260","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.2174\/092986710793205408","article-title":"Selective COX-1 inhibition: a therapeutic target to be reconsidered","volume":"17","author":"Perrone","year":"2010","journal-title":"Curr Med Chem"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295211004199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295211004199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T23:32:57Z","timestamp":1741303977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295211004199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0006295211004199"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2011.06.035","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}